APC and intestinal neoplasm: Although β-catenin mutations are observed at much lower frequencies than Apc in intestinal tumours (~5% compared to ~75%) [3], conditional activation of β-catenin is sufficient to induce tumourigenesis in the mouse intestine [149,150], supporting the model of cytoplasmic Wnt signalling components as regulators of intestinal cancer.